Annual Net Income:
-$200.40M-$23.28M(-13.15%)Summary
- As of today, LXRX annual net profit is -$200.40 million, with the most recent change of -$23.28 million (-13.15%) on December 31, 2024.
- During the last 3 years, LXRX annual net income has fallen by -$112.64 million (-128.36%).
- LXRX annual net income is now -254.00% below its all-time high of $130.13 million, reached on December 31, 2019.
Performance
LXRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
-$12.77M-$16.02M(-492.65%)Summary
- As of today, LXRX quarterly net profit is -$12.77 million, with the most recent change of -$16.02 million (-492.65%) on September 30, 2025.
- Over the past year, LXRX quarterly net income has increased by +$52.04 million (+80.30%).
- LXRX quarterly net income is now -105.65% below its all-time high of $226.09 million, reached on September 30, 2019.
Performance
LXRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
-$68.58M+$52.04M(+43.15%)Summary
- As of today, LXRX TTM net profit is -$68.58 million, with the most recent change of +$52.04 million (+43.15%) on September 30, 2025.
- Over the past year, LXRX TTM net income has increased by +$146.30 million (+68.09%).
- LXRX TTM net income is now -141.69% below its all-time high of $164.49 million, reached on September 30, 2019.
Performance
LXRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
LXRX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -13.2% | +80.3% | +68.1% |
| 3Y3 Years | -128.4% | +45.4% | +29.4% |
| 5Y5 Years | -254.0% | -115.5% | +34.2% |
LXRX Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -128.4% | at low | -492.6% | +80.3% | at high | +68.1% |
| 5Y | 5-Year | -254.0% | at low | -115.5% | +80.3% | -280.1% | +68.1% |
| All-Time | All-Time | -254.0% | at low | -105.7% | +81.5% | -141.7% | +68.1% |
LXRX Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$12.77M(-492.7%) | -$68.58M(+43.1%) |
| Jun 2025 | - | $3.25M(+112.9%) | -$120.62M(+32.0%) |
| Mar 2025 | - | -$25.30M(+25.1%) | -$177.30M(+11.5%) |
| Dec 2024 | -$200.40M(-13.1%) | -$33.77M(+47.9%) | -$200.40M(+6.7%) |
| Sep 2024 | - | -$64.81M(-21.3%) | -$214.88M(-7.1%) |
| Jun 2024 | - | -$53.43M(-10.4%) | -$200.59M(-4.4%) |
| Mar 2024 | - | -$48.40M(-0.3%) | -$192.07M(-9.4%) |
| Dec 2023 | -$177.12M(-73.7%) | -$48.24M(+4.5%) | -$175.61M(-11.2%) |
| Sep 2023 | - | -$50.52M(-12.5%) | -$157.86M(-20.8%) |
| Jun 2023 | - | -$44.90M(-40.6%) | -$130.72M(-18.4%) |
| Mar 2023 | - | -$31.93M(-4.7%) | -$110.40M(-8.3%) |
| Dec 2022 | -$101.94M(-16.2%) | -$30.49M(-30.4%) | -$101.94M(-5.0%) |
| Sep 2022 | - | -$23.39M(+4.9%) | -$97.06M(-0.3%) |
| Jun 2022 | - | -$24.59M(-4.7%) | -$96.80M(-7.2%) |
| Mar 2022 | - | -$23.48M(+8.3%) | -$90.28M(-2.9%) |
| Dec 2021 | -$87.76M(-49.8%) | -$25.61M(-10.8%) | -$87.76M(-29.7%) |
| Sep 2021 | - | -$23.12M(-28.0%) | -$67.64M(-277.6%) |
| Jun 2021 | - | -$18.07M(+13.8%) | $38.08M(+394.7%) |
| Mar 2021 | - | -$20.96M(-281.4%) | -$12.92M(+77.9%) |
| Dec 2020 | -$58.57M(-145.0%) | -$5.50M(-106.7%) | -$58.57M(+43.8%) |
| Sep 2020 | - | $82.60M(+219.6%) | -$104.22M(-365.4%) |
| Jun 2020 | - | -$69.07M(-3.7%) | $39.27M(-54.0%) |
| Mar 2020 | - | -$66.61M(-30.3%) | $85.32M(-34.4%) |
| Dec 2019 | $130.13M(+208.0%) | -$51.14M(-122.6%) | $130.13M(-20.9%) |
| Sep 2019 | - | $226.09M(+1082.2%) | $164.49M(+284.8%) |
| Jun 2019 | - | -$23.02M(-5.6%) | -$88.99M(+11.5%) |
| Mar 2019 | - | -$21.80M(-29.9%) | -$100.52M(+16.6%) |
| Dec 2018 | -$120.55M(+2.0%) | -$16.78M(+38.7%) | -$120.55M(+8.8%) |
| Sep 2018 | - | -$27.40M(+20.7%) | -$132.14M(+2.5%) |
| Jun 2018 | - | -$34.55M(+17.4%) | -$135.47M(+0.4%) |
| Mar 2018 | - | -$41.82M(-47.4%) | -$135.98M(-5.4%) |
| Dec 2017 | -$122.99M(+13.0%) | -$28.38M(+7.6%) | -$129.05M(+3.0%) |
| Sep 2017 | - | -$30.72M(+12.4%) | -$133.09M(+3.8%) |
| Jun 2017 | - | -$35.06M(-0.5%) | -$138.38M(+2.2%) |
| Mar 2017 | - | -$34.89M(-7.6%) | -$141.44M(-0.0%) |
| Dec 2016 | -$141.43M(-2920.7%) | -$32.42M(+10.0%) | -$141.43M(-29.7%) |
| Sep 2016 | - | -$36.02M(+5.5%) | -$109.01M(-0.7%) |
| Jun 2016 | - | -$38.11M(-9.3%) | -$108.28M(-10.2%) |
| Mar 2016 | - | -$34.88M(+1.1%) | -$98.24M(-4.1%) |
| Dec 2015 | -$4.68M(+95.3%) | - | - |
| Sep 2015 | - | -$35.28M(-25.7%) | -$94.36M(+5.2%) |
| Jun 2015 | - | -$28.07M(+0.0%) | -$99.58M(-2.1%) |
| Mar 2015 | - | -$28.08M(-857.2%) | -$97.53M(+2.8%) |
| Dec 2014 | -$100.29M(+3.7%) | -$2.93M(+92.8%) | -$100.29M(+12.6%) |
| Sep 2014 | - | -$40.50M(-55.6%) | -$114.78M(-8.3%) |
| Jun 2014 | - | -$26.03M(+15.6%) | -$105.94M(+2.8%) |
| Mar 2014 | - | -$30.84M(-77.1%) | -$108.99M(-4.7%) |
| Dec 2013 | -$104.13M(+5.5%) | -$17.41M(+45.0%) | -$104.13M(+6.7%) |
| Sep 2013 | - | -$31.66M(-8.9%) | -$111.58M(-1.9%) |
| Jun 2013 | - | -$29.08M(-12.0%) | -$109.47M(-3.0%) |
| Mar 2013 | - | -$25.97M(-4.4%) | -$106.32M(+3.5%) |
| Dec 2012 | -$110.21M | -$24.87M(+15.8%) | -$110.21M(+7.5%) |
| Sep 2012 | - | -$29.54M(-13.9%) | -$119.18M(-3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | -$25.93M(+13.2%) | -$115.75M(+0.6%) |
| Mar 2012 | - | -$29.87M(+11.8%) | -$116.45M(-0.2%) |
| Dec 2011 | -$116.22M(-14.2%) | -$33.84M(-29.7%) | -$116.22M(-10.3%) |
| Sep 2011 | - | -$26.10M(+2.0%) | -$105.37M(+1.3%) |
| Jun 2011 | - | -$26.64M(+10.1%) | -$106.78M(-1.4%) |
| Mar 2011 | - | -$29.63M(-28.8%) | -$105.33M(-3.5%) |
| Dec 2010 | -$101.78M(-9.1%) | -$23.00M(+16.4%) | -$101.78M(-1.0%) |
| Sep 2010 | - | -$27.51M(-9.2%) | -$100.78M(-13.4%) |
| Jun 2010 | - | -$25.19M(+3.4%) | -$88.88M(-10.7%) |
| Mar 2010 | - | -$26.07M(-18.5%) | -$80.30M(-2.2%) |
| Dec 2009 | -$93.32M(+3.7%) | -$22.00M(-40.9%) | -$78.56M(-15.6%) |
| Sep 2009 | - | -$15.62M(+6.0%) | -$67.96M(+15.8%) |
| Jun 2009 | - | -$16.60M(+31.8%) | -$80.74M(+10.6%) |
| Mar 2009 | - | -$24.34M(-113.4%) | -$90.32M(-1.6%) |
| Dec 2008 | -$96.88M(-36.0%) | -$11.40M(+59.8%) | -$88.86M(-4.1%) |
| Sep 2008 | - | -$28.40M(-8.5%) | -$85.36M(-13.9%) |
| Jun 2008 | - | -$26.18M(-14.5%) | -$74.94M(-12.4%) |
| Mar 2008 | - | -$22.87M(-189.3%) | -$66.65M(-6.3%) |
| Dec 2007 | -$71.23M(-31.2%) | -$7.91M(+56.0%) | -$62.70M(+8.6%) |
| Sep 2007 | - | -$17.98M(-0.5%) | -$68.61M(-8.2%) |
| Jun 2007 | - | -$17.89M(+5.4%) | -$63.39M(-1.6%) |
| Mar 2007 | - | -$18.91M(-36.8%) | -$62.40M(-14.9%) |
| Dec 2006 | -$54.31M(-49.6%) | -$13.82M(-8.4%) | -$54.31M(-57.1%) |
| Sep 2006 | - | -$12.76M(+24.5%) | -$34.57M(+3.8%) |
| Jun 2006 | - | -$16.90M(-56.1%) | -$35.94M(-6.1%) |
| Mar 2006 | - | -$10.83M(-283.1%) | -$33.88M(+6.7%) |
| Dec 2005 | -$36.31M(+23.0%) | $5.91M(+141.9%) | -$36.31M(+15.1%) |
| Sep 2005 | - | -$14.12M(+4.9%) | -$42.77M(+0.6%) |
| Jun 2005 | - | -$14.84M(-11.9%) | -$43.03M(+4.3%) |
| Mar 2005 | - | -$13.27M(-2352.1%) | -$44.97M(+4.7%) |
| Dec 2004 | -$47.17M(+22.8%) | -$541.00K(+96.2%) | -$47.17M(+19.3%) |
| Sep 2004 | - | -$14.38M(+14.4%) | -$58.43M(+0.3%) |
| Jun 2004 | - | -$16.79M(-8.5%) | -$58.61M(+1.4%) |
| Mar 2004 | - | -$15.47M(-31.1%) | -$59.44M(+2.7%) |
| Dec 2003 | -$61.12M(-2.4%) | -$11.80M(+18.9%) | -$61.12M(+3.3%) |
| Sep 2003 | - | -$14.56M(+17.4%) | -$63.18M(+3.4%) |
| Jun 2003 | - | -$17.62M(-2.8%) | -$65.44M(-4.3%) |
| Mar 2003 | - | -$17.14M(-23.7%) | -$62.76M(-5.2%) |
| Dec 2002 | -$59.67M(-69.7%) | -$13.86M(+17.5%) | -$59.67M(-5.0%) |
| Sep 2002 | - | -$16.81M(-12.5%) | -$56.81M(-22.9%) |
| Jun 2002 | - | -$14.94M(-6.3%) | -$46.22M(-12.1%) |
| Mar 2002 | - | -$14.06M(-27.8%) | -$41.22M(-17.2%) |
| Dec 2001 | -$35.17M(-35.3%) | -$11.01M(-76.9%) | -$35.17M(-11.0%) |
| Sep 2001 | - | -$6.22M(+37.4%) | -$31.69M(-17.3%) |
| Jun 2001 | - | -$9.94M(-24.1%) | -$27.01M(-31.2%) |
| Mar 2001 | - | -$8.01M(-6.5%) | -$20.58M(+20.8%) |
| Dec 2000 | -$25.99M(-108.4%) | -$7.52M(-388.3%) | -$25.99M(-40.7%) |
| Sep 2000 | - | -$1.54M(+56.2%) | -$18.47M(-9.1%) |
| Jun 2000 | - | -$3.52M(+73.8%) | -$16.93M(-26.2%) |
| Mar 2000 | - | -$13.42M | -$13.42M |
| Dec 1999 | -$12.48M(-66.8%) | - | - |
| Dec 1998 | -$7.48M(-38.5%) | - | - |
| Dec 1997 | -$5.40M(-87.6%) | - | - |
| Dec 1996 | -$2.88M | - | - |
FAQ
- What is Lexicon Pharmaceuticals, Inc. annual net profit?
- What is the all-time high annual net income for Lexicon Pharmaceuticals, Inc.?
- What is Lexicon Pharmaceuticals, Inc. annual net income year-on-year change?
- What is Lexicon Pharmaceuticals, Inc. quarterly net profit?
- What is the all-time high quarterly net income for Lexicon Pharmaceuticals, Inc.?
- What is Lexicon Pharmaceuticals, Inc. quarterly net income year-on-year change?
- What is Lexicon Pharmaceuticals, Inc. TTM net profit?
- What is the all-time high TTM net income for Lexicon Pharmaceuticals, Inc.?
- What is Lexicon Pharmaceuticals, Inc. TTM net income year-on-year change?
What is Lexicon Pharmaceuticals, Inc. annual net profit?
The current annual net income of LXRX is -$200.40M
What is the all-time high annual net income for Lexicon Pharmaceuticals, Inc.?
Lexicon Pharmaceuticals, Inc. all-time high annual net profit is $130.13M
What is Lexicon Pharmaceuticals, Inc. annual net income year-on-year change?
Over the past year, LXRX annual net profit has changed by -$23.28M (-13.15%)
What is Lexicon Pharmaceuticals, Inc. quarterly net profit?
The current quarterly net income of LXRX is -$12.77M
What is the all-time high quarterly net income for Lexicon Pharmaceuticals, Inc.?
Lexicon Pharmaceuticals, Inc. all-time high quarterly net profit is $226.09M
What is Lexicon Pharmaceuticals, Inc. quarterly net income year-on-year change?
Over the past year, LXRX quarterly net profit has changed by +$52.04M (+80.30%)
What is Lexicon Pharmaceuticals, Inc. TTM net profit?
The current TTM net income of LXRX is -$68.58M
What is the all-time high TTM net income for Lexicon Pharmaceuticals, Inc.?
Lexicon Pharmaceuticals, Inc. all-time high TTM net profit is $164.49M
What is Lexicon Pharmaceuticals, Inc. TTM net income year-on-year change?
Over the past year, LXRX TTM net profit has changed by +$146.30M (+68.09%)